866
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder

, , , &
Pages 259-268 | Published online: 22 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Krithika Rajagopalan, Kellie Meyer, Ken O’Day, Melissa Denno & Antony Loebel. (2015) Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression. Journal of Medical Economics 18:10, pages 821-827.
Read now

Articles from other publishers (10)

Anne Kleijburg, Joran Lokkerbol, Eline J. Regeer, Bart Geerling, Silvia M. A. A. Evers, Hans Kroon & Ben Wijnen. (2022) Designing and testing of a health-economic Markov model to assess the cost-effectiveness of treatments for Bipolar disorder: TiBipoMod. Frontiers in Psychiatry 13.
Crossref
Zubair Mahmood Kamal, Siddhartha Dutta, Sayeeda Rahman, Ayukafangha Etando, Emran Hasan, Sayeda Nazmun Nahar, Wan Farizatul Shima Wan Ahmad Fakuradzi, Susmita Sinha, Mainul Haque & Rahnuma Ahmad. (2022) Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review. Cureus.
Crossref
Margarida Augusto, Mallik Greene, Maëlys Touya, Samantha Min Sweeney & Heidi Waters. (2018) Cost–effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA. Journal of Comparative Effectiveness Research 7:7, pages 637-650.
Crossref
Ifigeneia Mavranezouli & Joran Lokkerbol. (2016) A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder. PharmacoEconomics 35:3, pages 271-296.
Crossref
Ana Flávia Barros da Silva Lima, Luciane Cruz, Mírian Cohen, Jacques José Zimmermann & Sandro René Pinto de Sousa Miguel. 2017. Mental Health Economics. Mental Health Economics 299 311 .
Anees Ahmed Abdul Pari, Judit Simon, Jane Wolstenholme, John R Geddes & Guy M Goodwin. (2014) Economic evaluations in bipolar disorder: a systematic review and critical appraisal. Bipolar Disorders 16:6, pages 557-582.
Crossref
Syed Mohiuddin. (2014) A Systematic and Critical Review of Model-Based Economic Evaluations of Pharmacotherapeutics in Patients with Bipolar Disorder. Applied Health Economics and Health Policy 12:4, pages 359-372.
Crossref
Michael Sonntag, Hans-Helmut König & Alexander Konnopka. (2013) The Estimation of Utility Weights in Cost-Utility Analysis for Mental Disorders: A Systematic Review. PharmacoEconomics 31:12, pages 1131-1154.
Crossref
Greg L. Plosker. (2012) Quetiapine. PharmacoEconomics 30:7, pages 611-631.
Crossref
Mattias Ekman, Peter Lindgren, Carolin Miltenburger, Genevieve Meier, Julie C. Locklear & Mary Lou Chatterton. (2012) Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode. PharmacoEconomics 30:6, pages 513-530.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.